To understand their place in the research hierarchy, it helps to distinguish them from other classes
Protocol overview: BPC-157 administered via subcutaneous injection, locally near the affected joint Standard dosing range: 200500 mcg per injection session Treatment duration: 48 weeks of active treatment Follow-up assessments: 6 months and 12 months post-treatment Patients were evaluated using validated pain scales (VAS and KOOS scores) and functional mobility assessments at each follow-up point
BPC-157: Over 100 preclinical studies, 25-plus years of research, multiple independent research groups, limited human clinical data, extensive physician-supervised clinical experience
GHK-Cu is supplied as a research peptide for laboratory and analytical use and is also widely used as a cosmetic ingredient in topical preparations under the relevant cosmetic ingredient regulatory frameworks
The combination L-carnitine + L-lysine therefore has an increased activity (potentiating or synergistic effect) which can be explained by an increase in the bioavailability of L-carnitine, at the level of the target organs, muscles and myocardium
